lidocaine has been researched along with Tachycardia, Ventricular in 146 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
Excerpt | Relevance | Reference |
---|---|---|
"More than 20 randomized trials and 4 meta-analyses have been conducted on the use of prophylactic lidocaine in acute myocardial infarction (MI)." | 10.19 | Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. ( Alexander, JH; Dyduszynski, A; Granger, CB; Kong, DF; Kuch, J; Nartowicz, E; Sadowski, ZP; Skrabucha, B; Swiatecka, G, 1999) |
"In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access." | 9.22 | Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. ( Aufderheide, TP; Brienza, AM; Brown, SP; Callaway, CW; Christenson, J; Colella, MR; Daya, M; Desvigne-Nickens, P; Dorian, P; Dunford, JV; Egan, D; Gray, PC; Gray, R; Idris, AH; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Nichol, G; Ornato, JP; Rea, T; Seals, N; Stiell, IG; Straight, R; Vaillancourt, C; Vilke, GM; Weisfeldt, ML; Wittwer, L, 2016) |
"Prospective evaluations of intravenous lidocaine as therapy for sustained monomorphic ventricular tachycardia (VT) in the absence of acute myocardial infarction are lacking." | 9.07 | Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction. ( Doyle, TK; Nasir, N; Pacifico, A; Taylor, A, 1994) |
" We included adult patients with shockable rhythms, such as ventricular fibrillation and pulseless ventricular tachycardia, who were administered either lidocaine or amiodarone." | 8.12 | Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry. ( Amagasa, S; Fukushima, F; Kashiura, M; Kishihara, Y; Moriya, T; Yasuda, H, 2022) |
"To determine the association between amiodarone and lidocaine and outcomes in children with cardiac arrest with pulseless ventricular tachycardia (pVT) and ventricular fibrillation (VF)." | 7.80 | Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. ( Berg, MD; Berg, RA; Donoghue, AJ; Hammond, R; Hoyme, DB; Samson, RA; Valdes, SO, 2014) |
" The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively." | 7.79 | Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction. ( Griffith, BP; Li, T; Sanchez, PG; Watkins, AC; Wei, X; Wu, ZJ, 2013) |
"To compare the efficacy and safety of nifekalant, a pure class III anti-arrhythmic drug, and lidocaine in patients with shock-resistant in-hospital ventricular fibrillation (VF) or ventricular tachycardia (VT)." | 7.76 | Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. ( Amino, M; Honda, T; Kasanuki, H; Kato, R; Katoh, T; Matsudo, Y; Ogawa, S; Sagara, K; Shiga, T; Takahashi, A; Takano, T; Tanaka, K; Urashima, M, 2010) |
" However, we found an unusual in utero presentation of intermittent atrioventricular block and ventricular tachycardia (spontaneous or lidocaine-induced) in a fetus and his sibling with LQTS." | 7.74 | In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant. ( Chahine, M; Chang, CC; Chiu, SN; Christé, G; Ficker, E; Huang, H; Lin, MT; Thériault, O; Wu, MH, 2008) |
"We performed a pilsicainide challenge test in a 38-year-old man who was resuscitated from ventricular fibrillation without apparent baseline electrocardiogram (ECG) abnormality." | 7.73 | Spontaneous polymorphic ventricular tachycardia after administration of pilsicainide in a patient resuscitated from ventricular fibrillation. ( Araki, S; Ogawa, H; Sadanaga, T; Tanaka, Y, 2006) |
"Despite continuing controversies regarding its antiarrhythmic and antifibrillatory efficacy lidocaine is frequently used for the treatment of ventricular arrhythmias occurring in the early phase of acute myocardial infarction (MI)." | 7.69 | Facilitation of reentry by lidocaine in canine myocardial infarction. ( Fazekas, T; Lazzara, R; Mabo, P; Patterson, E; Scherlag, BJ, 1994) |
"The purpose of this study was to investigate the effects of lidocaine and diltiazem on ventricular tachyarrhythmia and dispersion of conduction during severe myocardial ischemia in dogs." | 7.69 | Effects of lidocaine and diltiazem on ventricular tachyarrhythmia and dispersion of conduction during severe myocardial ischemia in canine hearts. ( Kuraoka, F; Kuroiwa, A; Murasato, Y; Nagamoto, Y; Nakashima, Y; Urabe, T, 1997) |
"The effects of lidocaine and diltiazem on recovery of electrophysiologic activity during partial reperfusion following severe myocardial ischemia were investigated in 28 dogs." | 7.69 | Effects of lidocaine and diltiazem on recovery of electrophysiologic activity during partial reperfusion following severe myocardial ischemia in canine hearts. ( Kuraoka, F; Kuroiwa, A; Murasato, Y; Nagamoto, Y; Nakashima, Y; Urabe, T, 1997) |
"We report on the experience accumulated by the subscribers of SHAHAL cardiac services who self-injected intramuscular lidocaine (using an automatic injector "LidoPen") for documented ventricular tachyarrhythmias which were not associated with an acute myocardial infarction." | 7.69 | Usefulness of self-administration of intramuscular lidocaine in the prehospital setting for ventricular tachyarrhythmias unassociated with acute myocardial infarction (the "Shahal" experience in Israel). ( Bloch, Y; Kaplinski, E; Laniado, S; Malov, N; Roth, A; Schlesinger, Z, 1997) |
"We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 7.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
"The authors studied the effects of lidocaine in 18 consecutive dogs with myocardial infarction 1 to 4 days after two-stage left anterior descending coronary artery ligation." | 7.69 | Facilitation of reentry by lidocaine in canine myocardial infarction. ( Fazekas, T; Lazzara, R; Mabo, P; Patterson, E; Scherlag, BJ, 1994) |
"The aim of the present study was to investigate the effect of lidocaine (L) on ventricular tachyarrhythmias with special reference to ventricular fibrillation (VF)." | 7.69 | Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction. ( Aidonidis, I; Brachmann, J; Kübler, W; Rizos, I; Toutouzas, P, 1994) |
"More than 20 randomized trials and 4 meta-analyses have been conducted on the use of prophylactic lidocaine in acute myocardial infarction (MI)." | 6.19 | Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. ( Alexander, JH; Dyduszynski, A; Granger, CB; Kong, DF; Kuch, J; Nartowicz, E; Sadowski, ZP; Skrabucha, B; Swiatecka, G, 1999) |
"Bupropion is an atypical antidepressant often used in the treatment of depression, tobacco cessation, seasonal affective disorder, and off label for ADHD." | 5.72 | Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine. ( Robinson, S, 2022) |
"Long QT syndrome is characterized by electrocardiographic appearance of long QT intervals and propensity to polymorphic ventricular tachycardia." | 5.38 | A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity. ( Montenegro, LM; Naim, M; Nathan, AT; Vetter, VL, 2012) |
"Repeated torsade de pointes tachycardia resulted in hemodynamic compromise and were terminated by defibrillations." | 5.31 | [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. ( Bauriedel, G; Lentini, S; Lüderitz, B; Rao, ML; Schröder, R, 2001) |
"No evidence of ischemic heart disease was detected." | 5.30 | Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia. ( Ito, H; Nakamura, W; Segawa, K; Tanaka, S; Yoshimoto, N, 1998) |
"In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access." | 5.22 | Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. ( Aufderheide, TP; Brienza, AM; Brown, SP; Callaway, CW; Christenson, J; Colella, MR; Daya, M; Desvigne-Nickens, P; Dorian, P; Dunford, JV; Egan, D; Gray, PC; Gray, R; Idris, AH; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Nichol, G; Ornato, JP; Rea, T; Seals, N; Stiell, IG; Straight, R; Vaillancourt, C; Vilke, GM; Weisfeldt, ML; Wittwer, L, 2016) |
"Prospective evaluations of intravenous lidocaine as therapy for sustained monomorphic ventricular tachycardia (VT) in the absence of acute myocardial infarction are lacking." | 5.07 | Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction. ( Doyle, TK; Nasir, N; Pacifico, A; Taylor, A, 1994) |
" We present a case secondary to Chagas disease that was responsive to lidocaine." | 4.12 | The imperfect storm: An uncommon presentation of Chagas disease. ( Johnson, MC; Wang, L, 2022) |
" We included adult patients with shockable rhythms, such as ventricular fibrillation and pulseless ventricular tachycardia, who were administered either lidocaine or amiodarone." | 4.12 | Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry. ( Amagasa, S; Fukushima, F; Kashiura, M; Kishihara, Y; Moriya, T; Yasuda, H, 2022) |
"To determine the association between amiodarone or lidocaine and outcomes in adult in-hospital cardiac arrest (IHCA) with shock-refractory ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT)." | 3.96 | Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia. ( Chang, WT; Chen, WJ; Huang, CH; Liu, YB; Tsai, MS; Wang, CH; Wu, YW; Yu, PH, 2020) |
"We administered intravenous pilsicainide to 245 consecutive patients with Brugada syndrome (181 patients with spontaneous type 1 ECG, 64 patients with non-type 1 ECG)." | 3.88 | Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome. ( Ito, H; Kawada, S; Miyamoto, M; Morimoto, Y; Morita, H; Nakagawa, K; Nishii, N; Tachibana, M; Ueoka, A; Watanabe, A, 2018) |
"Antiarrhythmic agents which belong to class Ia (quinidine) and Ic (flecainide) reportedly increase propensity to ventricular tachyarrhythmia, whereas class Ib agents (lidocaine and mexiletine) are recognized as safe antiarrhythmics." | 3.80 | Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization. ( Osadchii, OE, 2014) |
"To determine the association between amiodarone and lidocaine and outcomes in children with cardiac arrest with pulseless ventricular tachycardia (pVT) and ventricular fibrillation (VF)." | 3.80 | Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. ( Berg, MD; Berg, RA; Donoghue, AJ; Hammond, R; Hoyme, DB; Samson, RA; Valdes, SO, 2014) |
" The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively." | 3.79 | Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction. ( Griffith, BP; Li, T; Sanchez, PG; Watkins, AC; Wei, X; Wu, ZJ, 2013) |
"We conducted a retrospective analysis of ST-segment elevation myocardial infarction patients with sustained ventricular tachycardia/ventricular fibrillation in Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO) IIB and GUSTO III and compared all-cause death in patients receiving amiodarone, lidocaine, or no antiarrhythmic." | 3.77 | Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction. ( Alexander, JH; Ardissino, D; Califf, RM; Granger, CB; Mehta, RH; Ohman, EM; Piccini, JP; Pieper, KS; Schulte, PJ; Van de Werf, F; White, HD, 2011) |
"To compare the efficacy and safety of nifekalant, a pure class III anti-arrhythmic drug, and lidocaine in patients with shock-resistant in-hospital ventricular fibrillation (VF) or ventricular tachycardia (VT)." | 3.76 | Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. ( Amino, M; Honda, T; Kasanuki, H; Kato, R; Katoh, T; Matsudo, Y; Ogawa, S; Sagara, K; Shiga, T; Takahashi, A; Takano, T; Tanaka, K; Urashima, M, 2010) |
" However, we found an unusual in utero presentation of intermittent atrioventricular block and ventricular tachycardia (spontaneous or lidocaine-induced) in a fetus and his sibling with LQTS." | 3.74 | In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant. ( Chahine, M; Chang, CC; Chiu, SN; Christé, G; Ficker, E; Huang, H; Lin, MT; Thériault, O; Wu, MH, 2008) |
"We performed a pilsicainide challenge test in a 38-year-old man who was resuscitated from ventricular fibrillation without apparent baseline electrocardiogram (ECG) abnormality." | 3.73 | Spontaneous polymorphic ventricular tachycardia after administration of pilsicainide in a patient resuscitated from ventricular fibrillation. ( Araki, S; Ogawa, H; Sadanaga, T; Tanaka, Y, 2006) |
"We treated an 88-year-old man with aortic valvular stenosis/insufficiency and paroxysmal atrial fibrillation, who developed ventricular tachycardia due to pilsicainide toxicity." | 3.72 | A case of the toxicity of pilsicainide hydrochloride with comparison of the serial serum pilsicainide levels and electrocardiographic findings. ( Funada, A; Horita, Y; Kaku, B; Kanaya, H; Kitajima, S; Matsumura, M; Satoh, T; Uno, Y; Yamazaki, T, 2004) |
" Prenatal treatment with beta-adrenergic blocker (propranolol) and digitalis glycosides was prescribed because of suspicion of long QT syndrome occurring with fetal congestive heart failure." | 3.71 | Prenatal diagnosis and treatment of fetal long QT syndrome: a case report. ( Chang, IK; Chow, SN; Hsieh, FJ; Kau, ML; Ko, YH; Lee, CN; Shyu, MK, 2002) |
" During hospitalization, atrial fibrillation developed, and oral pilsicainide was administered." | 3.71 | Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. ( Aizawa, Y; Chinushi, M; Chinushi, Y; Toida, T, 2002) |
"Despite continuing controversies regarding its antiarrhythmic and antifibrillatory efficacy lidocaine is frequently used for the treatment of ventricular arrhythmias occurring in the early phase of acute myocardial infarction (MI)." | 3.69 | Facilitation of reentry by lidocaine in canine myocardial infarction. ( Fazekas, T; Lazzara, R; Mabo, P; Patterson, E; Scherlag, BJ, 1994) |
"The aim of the present study was to investigate the effect of lidocaine (L) on ventricular tachyarrhythmias with special reference to ventricular fibrillation (VF)." | 3.69 | Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction. ( Aidonidis, I; Brachmann, J; Kübler, W; Rizos, I; Toutouzas, P, 1994) |
"The authors studied the effects of lidocaine in 18 consecutive dogs with myocardial infarction 1 to 4 days after two-stage left anterior descending coronary artery ligation." | 3.69 | Facilitation of reentry by lidocaine in canine myocardial infarction. ( Fazekas, T; Lazzara, R; Mabo, P; Patterson, E; Scherlag, BJ, 1994) |
"We report on the experience accumulated by the subscribers of SHAHAL cardiac services who self-injected intramuscular lidocaine (using an automatic injector "LidoPen") for documented ventricular tachyarrhythmias which were not associated with an acute myocardial infarction." | 3.69 | Usefulness of self-administration of intramuscular lidocaine in the prehospital setting for ventricular tachyarrhythmias unassociated with acute myocardial infarction (the "Shahal" experience in Israel). ( Bloch, Y; Kaplinski, E; Laniado, S; Malov, N; Roth, A; Schlesinger, Z, 1997) |
"We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 3.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
"The effects of lidocaine and diltiazem on recovery of electrophysiologic activity during partial reperfusion following severe myocardial ischemia were investigated in 28 dogs." | 3.69 | Effects of lidocaine and diltiazem on recovery of electrophysiologic activity during partial reperfusion following severe myocardial ischemia in canine hearts. ( Kuraoka, F; Kuroiwa, A; Murasato, Y; Nagamoto, Y; Nakashima, Y; Urabe, T, 1997) |
"The purpose of this study was to investigate the effects of lidocaine and diltiazem on ventricular tachyarrhythmia and dispersion of conduction during severe myocardial ischemia in dogs." | 3.69 | Effects of lidocaine and diltiazem on ventricular tachyarrhythmia and dispersion of conduction during severe myocardial ischemia in canine hearts. ( Kuraoka, F; Kuroiwa, A; Murasato, Y; Nagamoto, Y; Nakashima, Y; Urabe, T, 1997) |
" Routine use of intravenous sodium bicarbonate is recommended to combat the severe metabolic acidosis accompanying cardiac arrest." | 3.64 | THE CHEMOTHERAPY OF CARDIAC ARREST. ( MINUCK, M, 1965) |
"An intravenous bolus injection and subsequent continuous infusion of NIF at a relatively low dosage were effective in treating severe ventricular tachyarrhythmias complicating ACS, reducing the potential risk of proarrhythmia." | 2.74 | Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome. ( Abe, A; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Shimizu, H; Tsukada, T; Yoshino, H; Yusu, S, 2009) |
"Procainamide 10 mg/kg was given intravenously with an injection speed of 100 mg/min, and lidocaine was administered at an intravenous dose of 1." | 2.68 | Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. ( Gorgels, AP; Hofs, A; Mulleneers, R; Smeets, JL; van den Dool, A; Vos, MA; Wellens, HJ, 1996) |
"The mean number of runs of ventricular tachycardia per patient was 0." | 2.67 | Lidocaine prophylaxis in coronary revascularization patients: a randomized, prospective trial. ( Goldberger, AL; Johnson, RG; Schwartz, M; Sirois, C; Thurer, RL; Weintraub, RM, 1993) |
"Sotalol was significantly more effective than lignocaine whether analysed on an intention-to-treat basis (69% vs 18%; 95% confidence interval for absolute difference of 51% 22-80%, p = 0." | 2.67 | Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia. ( Ho, DS; Richards, DA; Ross, DL; Uther, JB; Zecchin, RP, 1994) |
"Amiodarone is an antiarrhythmic medication used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias." | 2.47 | Amiodarone supplants lidocaine in ACLS and CPR protocols. ( Camporesi, EM; Mangar, D; Mizzi, A; Tran, T, 2011) |
"Amiodarone is a highly efficacious antiarrhythmic agent for many cardiac arrhythmias, ranging from atrial fibrillation to malignant ventricular tachyarrhythmias, and seems to be superior to other antiarrhythmic agents." | 2.42 | Arrhythmias in the intensive care patient. ( Brandts, B; Trappe, HJ; Weismueller, P, 2003) |
"Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported." | 1.91 | Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift? ( Bracy, CL; Gupta, R; Hockstein, MA; Hockstein, MJ; Kobres, PY; Lam, PH; Rao, SD; Sheikh, FH, 2023) |
"Bupropion is an atypical antidepressant often used in the treatment of depression, tobacco cessation, seasonal affective disorder, and off label for ADHD." | 1.72 | Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine. ( Robinson, S, 2022) |
"While monomorphic ventricular tachycardia and PVC-triggered polymorphic ventricular tachycardia may sometimes be amenable to successful ablation, some patients may be too critically ill to make such an approach feasible." | 1.46 | Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks. ( Boortz-Marx, R; Fudim, M; Patel, CB; Piccini, JP; Sun, AY, 2017) |
"We present a case of seizure activity in a woman in whom EKG led to a diagnosis of intermittent monomorphic and polymorphic ventricular tachycardia (torsades de pointes), highlighting the need for careful consideration of alternative causes of seizures, even in patients with known epilepsy." | 1.46 | Ventricular tachycardia and prolonged QT interval presenting as seizure-like activity. ( Mitchell, SH; Morris, SC; Wentlandt, M, 2017) |
"Idiopathic left ventricular tachycardia of the Belhassen type is rare in infants." | 1.42 | Verapamil-sensitive idiopathic left ventricular tachycardia in a 6-month-old: unique considerations in diagnosis and management in an infant. ( Cocalis, M; Foltz, R; Hiremath, G; Li, W; Roy-Burman, A; Tanel, RE, 2015) |
"No arrhythmia was induced by lidocaine." | 1.40 | Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig. ( Osadchii, OE, 2014) |
"Recent guidelines for treating ventricular fibrillation (VF) and ventricular tachycardia (VT) stress class III antiarrhythmic drugs, but some malignant arrhythmias refractory to these agents still occur in clinical practice." | 1.40 | Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era. ( Ikeda, U; Miura, T; Motoki, H; Okada, A; Takeuchi, T; Tomita, T; Yoshie, K, 2014) |
"Bidirectional ventricular tachycardia (BVT) is an uncommon type of polymorphic ventricular tachycardia (PVT) with alternating polarity of the QRS complex most commonly described digitalis toxicity." | 1.38 | Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation. ( Bhavnani, SP; Clyne, CA, 2012) |
"Long QT syndrome is characterized by electrocardiographic appearance of long QT intervals and propensity to polymorphic ventricular tachycardia." | 1.38 | A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity. ( Montenegro, LM; Naim, M; Nathan, AT; Vetter, VL, 2012) |
"Ranolazine is a drug that exerts antianginal and antiischemic effects and also acts as an antiarrhythmic in isolation and in combination with other class III medications." | 1.37 | Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. ( Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP, 2011) |
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in the cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) and can be difficult to treat." | 1.37 | Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. ( Faggioni, M; Hasdemir, C; Hwang, HS; Knollmann, BC; Laver, D; Mehra, D; Turhan, K; Yin, H, 2011) |
"Duration of ventricular tachycardia (VT) episodes was reduced from 15." | 1.37 | First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model. ( Bhandari, A; Dow, JS; Kloner, RA, 2011) |
"Hydrofluoric acid (HF) is a weak inorganic acid used for etching and as rust remover." | 1.35 | Recurrent life-threatening ventricular dysrhythmias associated with acute hydrofluoric acid ingestion: observations in one case and implications for mechanism of toxicity. ( Benitez, FL; Delaney, KA; Rivera, W; Velez, LI; Vohra, R, 2008) |
" Inadequate dosing and later administration of amiodarone in the code were two confounding factors in this study." | 1.33 | Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. ( Henderson, SO; Idrees, U; Kane-Gill, SL; Kirisci, L; Ou, NN; Oyen, LJ; Rea, RS; Rudis, MI; Seybert, AL; Stauss, JL, 2006) |
"As electrocardiography (ECG) revealed ventricular tachycardia (VT), cardioversion was administered but was unsuccessful." | 1.33 | [Case in which magnesium sulfate effectively treated ventricular tachycardia due to overdose of pilsicainide hydrochloride]. ( Mato, T; Moriwaki, R; Nakata, K; Takenouchi, S; Tsutsumi, H; Yamaguchi, A, 2006) |
"Idiopathic ventricular tachycardia is rare, especially in infants." | 1.32 | Verapamil sensitive idiopathic ventricular tachycardia in an infant. ( Chi, CS; Fu, YC; Jan, SL; Wang, JD, 2003) |
"Five days later, ventricular tachycardia following short-coupled ventricular premature contractions suddenly occurred and was not responsive to class IB drugs (lidocaine and mexiletine), requiring frequent electrical cardioversion." | 1.32 | Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach. ( Fu, LT; Iinuma, H; Sagara, K; Sahara, M; Watanabe, H; Yamashita, T, 2003) |
"Procainamide and lidocaine were infused to equipotent plasma concentrations in canines with three-day-old myocardial infarction." | 1.32 | Spatiotemporal dynamics of reentrant ventricular tachycardias in canine myocardial infarction: pharmacological modulation. ( Cardinal, R; Hélie, F; Vinet, A, 2003) |
"Nifekalant hydrochloride(NIF) is a novel class III antiarrhythmic agent for malignant VT/VF." | 1.32 | [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest]. ( Amino, M; Ban, K; Deguchi, Y; Fujikura, H; Goto, S; Handa, S; Inokuchi, S; Iwase, H; Iwata, O; Marutani, Y; Morita, S; Nakagawa, Y; Shiina, Y; Tanabe, T; Yamamoto, I; Yoshioka, K, 2003) |
"Our objective was to elucidate the mechanism of pharmacokinetic interaction between lidocaine and mexiletine, because an unexpected increase in plasma lidocaine concentration accompanied by severe side effects was observed when mexiletine was administered to a patient with dilated cardiomyopathy." | 1.31 | Possible mechanism for pharmacokinetic interaction between lidocaine and mexiletine. ( Fukuzawa, M; Funakoshi, S; Kugaya, Y; Maeda, Y; Murakami, T; Nakamura, M; Takano, M; Tsukiai, S; Yamasaki, M, 2002) |
"Repeated torsade de pointes tachycardia resulted in hemodynamic compromise and were terminated by defibrillations." | 1.31 | [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. ( Bauriedel, G; Lentini, S; Lüderitz, B; Rao, ML; Schröder, R, 2001) |
"Verapamil was infused into the superior vena cava over 15-20 min." | 1.30 | Effects of verapamil in ventricular tachycardias. An experimental and clinical study. ( Casanova, JM; De Micheli, A; Iturralde, P; Medrano, GA, 1997) |
"Only 2 patients with sustained ventricular tachycardia had a concurrent MI, and the tachycardia was unresponsive to initial lidocaine bolus in both cases." | 1.30 | Analysis of the treatment of spontaneous sustained stable ventricular tachycardia. ( Greenberg, GM; Kay, D; Marill, KA; Nelson, BK, 1997) |
"No evidence of ischemic heart disease was detected." | 1.30 | Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia. ( Ito, H; Nakamura, W; Segawa, K; Tanaka, S; Yoshimoto, N, 1998) |
"Patient 1 had frequent episodes of paroxysmal atrial fibrillation resistant to Class IA drugs." | 1.30 | ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. ( Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nagasawa, H; Usui, M, 1999) |
"To investigate out-of-hospital ventricular tachycardia (VT) cardiac arrest patients, comparing the prevalences and outcomes of the following VT subtypes among this population: monomorphic VT (MVT), polymorphic VT (PVT), and torsades de pointes (TdP, PVT with a prolonged QT interval)." | 1.30 | Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes. ( Brady, WJ; DeBehnke, DJ; Laundrie, D, 1999) |
"Orphenadrine is an anticholinergic drug used mainly in the treatment of Parkinson's disease." | 1.30 | Orphenadrine poisoning in a child: clinical and analytical data. ( Maes, V; Mertens, K; Ramet, J; Van Herreweghe, I, 1999) |
"After the appearance of ventricular tachycardia, they were treated with magnesium sulfate (45 mg/kg + 15 mg/kg/min) or lidocaine (1 mg/kg + 0." | 1.29 | Effects of magnesium sulfate and lidocaine in the treatment of ventricular arrhythmias in experimental amitriptyline poisoning in the rat. ( Abrahamsson, J; Knudsen, K, 1994) |
"Inducibility of sustained monomorphic ventricular tachycardia (SMVT) was compared in the pre-drug state, and after i." | 1.29 | The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart. ( Berlin, KD; Chen, CL; Fazekas, T; Garrison, GL; Lazzara, R; Mabo, P; Patterson, E; Sangiah, S; Scherlag, BJ, 1993) |
"Severe hypertension, ventricular tachycardia and subendocardial ischaemia occurred during the manipulation of adrenal gland in a patient who underwent live related donor nephrectomy." | 1.29 | Hypertension and tachycardia during adrenal manipulation. ( Sikora, R; Tewari, P, 1995) |
"8 mg/min at a constant rate infusion following a 100 mg bolus) combined with magnesium sulfate (M) (2." | 1.29 | Low dose lidocaine combined with magnesium sulfate in warning ventricular arrhythmias. ( Battaglia, A; Bertanelli, F; Bertoncini, G; Biondo, L; Fabiano, P; Leone, A; Mori, L, 1993) |
"Idiopathic ventricular tachycardia (VT) with the right bundle branch block pattern and left-axis deviation has been shown to be due to reentry, but the property of the slow conduction zone within the reentry circuit is little understood." | 1.29 | Characteristics of slow conduction zone demonstrated during entrainment of idiopathic ventricular tachycardia of left ventricular origin. ( Iwasa, A; Okumura, K; Tabuchi, T; Tsuchiya, T; Yamabe, H; Yasue, H, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.68) | 18.7374 |
1990's | 53 (36.30) | 18.2507 |
2000's | 49 (33.56) | 29.6817 |
2010's | 36 (24.66) | 24.3611 |
2020's | 7 (4.79) | 2.80 |
Authors | Studies |
---|---|
Garrison, GL | 2 |
Berlin, KD | 2 |
Scherlag, BJ | 4 |
Lazzara, R | 4 |
Patterson, E | 4 |
Fazekas, T | 4 |
Sangiah, S | 2 |
Chen, CL | 2 |
Schubot, FD | 1 |
van der Helm, D | 1 |
Robinson, S | 1 |
Johnson, MC | 1 |
Wang, L | 2 |
Kishihara, Y | 1 |
Kashiura, M | 1 |
Amagasa, S | 1 |
Fukushima, F | 1 |
Yasuda, H | 1 |
Moriya, T | 1 |
Bracy, CL | 1 |
Kobres, PY | 1 |
Hockstein, MJ | 1 |
Rao, SD | 1 |
Gupta, R | 1 |
Lam, PH | 1 |
Sheikh, FH | 1 |
Hockstein, MA | 1 |
Boles, U | 1 |
Refila, B | 1 |
Gul, EE | 1 |
Szeplaki, G | 1 |
Keaney, J | 1 |
Galvin, J | 1 |
Keelan, E | 1 |
Liu, CM | 1 |
Lin, FZ | 1 |
Chen, YC | 1 |
Lin, YK | 1 |
Lu, YY | 1 |
Wu, CI | 1 |
Higa, S | 1 |
Chen, SA | 1 |
Chen, YJ | 1 |
Katz, DJ | 1 |
Feduska, E | 1 |
Thoma, BN | 1 |
Goldhammer, JE | 1 |
Soar, J | 1 |
Mittal, S | 1 |
Mohan, A | 1 |
Madan, K | 1 |
Santangeli, P | 1 |
Ueoka, A | 1 |
Morita, H | 1 |
Watanabe, A | 1 |
Morimoto, Y | 1 |
Kawada, S | 1 |
Tachibana, M | 1 |
Miyamoto, M | 1 |
Nakagawa, K | 1 |
Nishii, N | 1 |
Ito, H | 2 |
Tunney, RK | 1 |
Whyte, K | 1 |
DeAntonio, HJ | 1 |
Panchal, AR | 1 |
Berg, KM | 1 |
Kudenchuk, PJ | 2 |
Del Rios, M | 1 |
Hirsch, KG | 1 |
Link, MS | 1 |
Kurz, MC | 1 |
Chan, PS | 1 |
Cabañas, JG | 1 |
Morley, PT | 1 |
Hazinski, MF | 2 |
Donnino, MW | 1 |
Duff, JP | 1 |
Topjian, A | 1 |
Berg, MD | 2 |
Chan, M | 1 |
Haskell, SE | 1 |
Joyner, BL | 1 |
Lasa, JJ | 1 |
Ley, SJ | 1 |
Raymond, TT | 1 |
Sutton, RM | 1 |
Atkins, DL | 1 |
Wang, CH | 1 |
Chang, WT | 1 |
Huang, CH | 1 |
Tsai, MS | 1 |
Yu, PH | 1 |
Wu, YW | 1 |
Liu, YB | 1 |
Chen, WJ | 1 |
Le, DD | 1 |
Abraham, AS | 1 |
Vinson, DR | 1 |
Li, T | 1 |
Wei, X | 1 |
Watkins, AC | 1 |
Sanchez, PG | 1 |
Wu, ZJ | 1 |
Griffith, BP | 1 |
Osadchii, OE | 2 |
Valdes, SO | 1 |
Donoghue, AJ | 1 |
Hoyme, DB | 1 |
Hammond, R | 1 |
Berg, RA | 1 |
Samson, RA | 1 |
Yoshie, K | 1 |
Tomita, T | 1 |
Takeuchi, T | 1 |
Okada, A | 1 |
Miura, T | 1 |
Motoki, H | 1 |
Ikeda, U | 1 |
Hiremath, G | 1 |
Li, W | 1 |
Foltz, R | 1 |
Roy-Burman, A | 1 |
Cocalis, M | 1 |
Tanel, RE | 1 |
Brown, SP | 1 |
Daya, M | 1 |
Rea, T | 1 |
Nichol, G | 1 |
Morrison, LJ | 1 |
Leroux, B | 1 |
Vaillancourt, C | 1 |
Wittwer, L | 1 |
Callaway, CW | 1 |
Christenson, J | 1 |
Egan, D | 1 |
Ornato, JP | 1 |
Weisfeldt, ML | 1 |
Stiell, IG | 1 |
Idris, AH | 1 |
Aufderheide, TP | 1 |
Dunford, JV | 1 |
Colella, MR | 1 |
Vilke, GM | 1 |
Brienza, AM | 1 |
Desvigne-Nickens, P | 1 |
Gray, PC | 1 |
Gray, R | 1 |
Seals, N | 1 |
Straight, R | 1 |
Dorian, P | 2 |
Long, B | 1 |
Koyfman, A | 1 |
Wentlandt, M | 1 |
Morris, SC | 1 |
Mitchell, SH | 1 |
Beyer, A | 1 |
Ganti, B | 1 |
Majkrzak, A | 1 |
Theyyunni, N | 1 |
Fudim, M | 1 |
Boortz-Marx, R | 1 |
Patel, CB | 1 |
Sun, AY | 1 |
Piccini, JP | 2 |
Dukkipati, SR | 1 |
Mallozzi, R | 1 |
Schmidt, EJ | 1 |
Holmvang, G | 1 |
d'Avila, A | 1 |
Guhde, R | 1 |
Darrow, RD | 1 |
Slavin, G | 1 |
Fung, M | 1 |
Malchano, Z | 1 |
Kampa, G | 1 |
Dando, JD | 1 |
McPherson, C | 1 |
Foo, TK | 1 |
Ruskin, JN | 1 |
Dumoulin, CL | 1 |
Reddy, VY | 1 |
Lin, MT | 1 |
Wu, MH | 2 |
Chang, CC | 2 |
Chiu, SN | 1 |
Thériault, O | 1 |
Huang, H | 1 |
Christé, G | 1 |
Ficker, E | 1 |
Chahine, M | 2 |
Sucu, MM | 1 |
Davutoglu, V | 1 |
Kalimullah, EA | 1 |
Bryant, SM | 1 |
Dosdall, DJ | 1 |
Yusu, S | 1 |
Ikeda, T | 1 |
Mera, H | 1 |
Miyakoshi, M | 1 |
Miwa, Y | 1 |
Abe, A | 1 |
Tsukada, T | 1 |
Ishiguro, H | 1 |
Shimizu, H | 1 |
Yoshino, H | 1 |
Shiga, T | 1 |
Tanaka, K | 1 |
Kato, R | 1 |
Amino, M | 2 |
Matsudo, Y | 1 |
Honda, T | 2 |
Sagara, K | 4 |
Takahashi, A | 1 |
Katoh, T | 1 |
Urashima, M | 1 |
Ogawa, S | 2 |
Takano, T | 1 |
Kasanuki, H | 1 |
Lu, HR | 1 |
Rohrbacher, J | 1 |
Vlaminckx, E | 1 |
Van Ammel, K | 1 |
Yan, GX | 1 |
Gallacher, DJ | 1 |
Komura, S | 1 |
Chinushi, M | 2 |
Furushima, H | 1 |
Hosaka, Y | 1 |
Izumi, D | 1 |
Iijima, K | 1 |
Watanabe, H | 3 |
Yagihara, N | 1 |
Aizawa, Y | 3 |
Hisada, T | 1 |
Miyagawa, T | 1 |
Yakushiji, T | 1 |
Tsujimoto, T | 1 |
Sakai, M | 1 |
Adachi, T | 1 |
Ikewaki, K | 1 |
Ogata, K | 1 |
Ohsuzu, F | 1 |
Sakurai, Y | 1 |
Nakagawa, H | 1 |
Honjo, H | 1 |
Ishiguro, YS | 1 |
Yamazaki, M | 1 |
Okuno, Y | 1 |
Harada, M | 1 |
Takanari, H | 1 |
Sakuma, I | 1 |
Kamiya, K | 1 |
Kodama, I | 1 |
Schulte, PJ | 1 |
Pieper, KS | 1 |
Mehta, RH | 1 |
White, HD | 1 |
Van de Werf, F | 1 |
Ardissino, D | 1 |
Califf, RM | 1 |
Granger, CB | 2 |
Ohman, EM | 1 |
Alexander, JH | 2 |
Auer, J | 1 |
Lamm, G | 1 |
Kloner, RA | 1 |
Dow, JS | 1 |
Bhandari, A | 1 |
Hwang, HS | 1 |
Hasdemir, C | 1 |
Laver, D | 1 |
Mehra, D | 1 |
Turhan, K | 1 |
Faggioni, M | 1 |
Yin, H | 1 |
Knollmann, BC | 1 |
Allen, NM | 1 |
Azam, M | 1 |
Dunne, KP | 1 |
Walsh, KP | 1 |
Mizzi, A | 1 |
Tran, T | 1 |
Mangar, D | 1 |
Camporesi, EM | 1 |
Bunch, TJ | 1 |
Mahapatra, S | 1 |
Murdock, D | 1 |
Molden, J | 1 |
Weiss, JP | 1 |
May, HT | 1 |
Bair, TL | 1 |
Mader, KM | 1 |
Crandall, BG | 1 |
Day, JD | 1 |
Osborn, JS | 1 |
Muhlestein, JB | 1 |
Lappe, DL | 1 |
Anderson, JL | 1 |
Nathan, AT | 1 |
Naim, M | 1 |
Montenegro, LM | 1 |
Vetter, VL | 1 |
Kaneko, Y | 1 |
Nakajima, T | 1 |
Kato, T | 1 |
Kurabayashi, M | 1 |
Hoffmann, C | 1 |
Falzone, E | 1 |
Augé, M | 1 |
Dinanian, S | 1 |
Mercier, FJ | 1 |
Bhavnani, SP | 1 |
Clyne, CA | 1 |
Somberg, JC | 1 |
Bailin, SJ | 1 |
Haffajee, CI | 1 |
Paladino, WP | 1 |
Kerin, NZ | 1 |
Bridges, D | 1 |
Timar, S | 1 |
Molnar, J | 1 |
Chang, IK | 1 |
Shyu, MK | 1 |
Lee, CN | 1 |
Kau, ML | 1 |
Ko, YH | 1 |
Chow, SN | 1 |
Hsieh, FJ | 1 |
Singh, D | 1 |
Dutta, S | 1 |
Narang, A | 1 |
Yoshioka, K | 1 |
Iwata, O | 1 |
Fujikura, H | 1 |
Deguchi, Y | 1 |
Ban, K | 1 |
Shiina, Y | 1 |
Goto, S | 1 |
Handa, S | 1 |
Tanabe, T | 1 |
Nakagawa, Y | 1 |
Morita, S | 1 |
Iwase, H | 1 |
Yamamoto, I | 1 |
Inokuchi, S | 1 |
Marutani, Y | 1 |
Hélie, F | 2 |
Vinet, A | 2 |
Cardinal, R | 3 |
Sahara, M | 2 |
Yamashita, T | 2 |
Iinuma, H | 2 |
Fu, LT | 2 |
Cengiz, P | 1 |
Shah, M | 1 |
MINUCK, M | 1 |
Srivatsa, UN | 1 |
Ebrahimi, R | 1 |
El-Bialy, A | 1 |
Wachsner, RY | 1 |
Trappe, HJ | 1 |
Brandts, B | 1 |
Weismueller, P | 1 |
Mioni, C | 1 |
Giuliani, D | 1 |
Cainazzo, MM | 1 |
Leone, S | 1 |
Iannone, A | 1 |
Bazzani, C | 1 |
Grieco, P | 1 |
Novellino, E | 1 |
Tomasi, A | 1 |
Bertolini, A | 1 |
Guarini, S | 1 |
Wang, JD | 1 |
Fu, YC | 1 |
Jan, SL | 1 |
Chi, CS | 1 |
Kimura, M | 1 |
Kobayashi, T | 1 |
Owada, S | 1 |
Ashikaga, K | 2 |
Higuma, T | 1 |
Sasaki, S | 1 |
Iwasa, A | 3 |
Motomura, S | 1 |
Okumura, K | 3 |
Sivasubramonian, S | 1 |
Rosenthal, E | 1 |
Takada, Y | 1 |
Isobe, S | 1 |
Okada, M | 1 |
Ando, A | 1 |
Nonokawa, M | 1 |
Inden, Y | 1 |
Tomita, Y | 1 |
Suzuki, A | 1 |
Hirai, M | 1 |
Murohara, T | 1 |
Canyon, SJ | 1 |
Dobson, GP | 1 |
Kanemoto, M | 1 |
Shimizu, A | 2 |
Yamagata, T | 1 |
Esato, M | 2 |
Ueyama, T | 2 |
Yoshiga, Y | 2 |
Kakugawa, H | 1 |
Kametani, R | 1 |
Inoue, N | 1 |
Sawa, A | 2 |
Matsuzaki, M | 2 |
Tsou, CH | 1 |
Chiang, CE | 1 |
Kao, T | 1 |
Jawan, B | 1 |
Luk, HN | 1 |
Acharfi, S | 1 |
Chiang, FT | 1 |
Wang, JK | 1 |
Sung, TC | 1 |
Horita, Y | 1 |
Kanaya, H | 1 |
Uno, Y | 1 |
Yamazaki, T | 1 |
Kaku, B | 1 |
Funada, A | 1 |
Kitajima, S | 1 |
Matsumura, M | 1 |
Satoh, T | 1 |
Baranwal, AK | 1 |
Mandal, RN | 1 |
Singh, R | 1 |
Singhi, SC | 1 |
You, B | 1 |
Pu, J | 1 |
Liu, N | 1 |
Yu, R | 1 |
Ruan, Y | 1 |
Li, Y | 1 |
Nakata, K | 1 |
Moriwaki, R | 1 |
Yamaguchi, A | 1 |
Takenouchi, S | 1 |
Mato, T | 1 |
Tsutsumi, H | 1 |
Rea, RS | 1 |
Kane-Gill, SL | 1 |
Rudis, MI | 1 |
Seybert, AL | 1 |
Oyen, LJ | 1 |
Ou, NN | 1 |
Stauss, JL | 1 |
Kirisci, L | 1 |
Idrees, U | 1 |
Henderson, SO | 1 |
Nagai, T | 1 |
Suyama, K | 1 |
Shimizu, W | 2 |
Noda, T | 2 |
Satomi, K | 1 |
Kurita, T | 1 |
Aihara, N | 1 |
Kamakura, S | 1 |
Aiba, T | 1 |
Hidaka, I | 1 |
Uemura, K | 1 |
Zheng, C | 1 |
Kamiya, A | 1 |
Inagaki, M | 1 |
Sugimachi, M | 1 |
Sunagawa, K | 1 |
Sajeev, CG | 1 |
Francis, J | 1 |
Sankar, V | 1 |
Vasudev, B | 1 |
Venugopal, K | 1 |
Lang, E | 1 |
Al Raisi, M | 1 |
Sadanaga, T | 1 |
Araki, S | 1 |
Tanaka, Y | 2 |
Ogawa, H | 1 |
Shinohara, T | 1 |
Takahashi, N | 1 |
Saikawa, T | 1 |
Yoshimatsu, H | 1 |
Yamawake, N | 1 |
Nishizaki, M | 1 |
Hayashi, T | 1 |
Niki, S | 1 |
Maeda, S | 1 |
Fujii, H | 1 |
Ashikaga, T | 1 |
Sakurada, H | 1 |
Hiraoka, M | 1 |
Vohra, R | 1 |
Velez, LI | 1 |
Rivera, W | 1 |
Benitez, FL | 1 |
Delaney, KA | 1 |
Suzuki, S | 1 |
Sugi, N | 1 |
Algren, DA | 1 |
Sutter, ME | 1 |
Ludot, H | 1 |
Tharin, JY | 1 |
Belouadah, M | 1 |
Mazoit, JX | 1 |
Malinovsky, JM | 1 |
Mabo, P | 3 |
Schechter, WS | 1 |
Kim, C | 1 |
Martinez, M | 1 |
Gleason, BF | 1 |
Lund, DP | 1 |
Burrows, FA | 1 |
Tewari, P | 1 |
Sikora, R | 1 |
Leone, A | 1 |
Biondo, L | 1 |
Fabiano, P | 1 |
Mori, L | 1 |
Bertoncini, G | 1 |
Battaglia, A | 1 |
Bertanelli, F | 1 |
Aidonidis, I | 1 |
Brachmann, J | 1 |
Rizos, I | 1 |
Toutouzas, P | 1 |
Kübler, W | 1 |
Traub-Dargatz, JL | 1 |
Schlipf, JW | 1 |
Boon, J | 1 |
Ogilvie, GK | 1 |
Bennett, DG | 1 |
Wingfield, WE | 1 |
Hutchison, JM | 1 |
Cossette, J | 1 |
Vermeulen, M | 2 |
Janssen, JH | 1 |
Meldon, SW | 1 |
Brady, WJ | 2 |
Berger, S | 1 |
Mannenbach, M | 1 |
Ho, DS | 1 |
Zecchin, RP | 1 |
Richards, DA | 1 |
Uther, JB | 1 |
Ross, DL | 1 |
Nasir, N | 1 |
Taylor, A | 1 |
Doyle, TK | 1 |
Pacifico, A | 1 |
Knudsen, K | 1 |
Abrahamsson, J | 1 |
Gutiérrez-Larraya, F | 1 |
Jabón, A | 1 |
Christie, JM | 1 |
Valdes, C | 1 |
Markowsky, SJ | 1 |
Ishibashi, H | 1 |
Fu, L | 1 |
Namiki, T | 1 |
Sekiguchi, A | 1 |
Kato, K | 1 |
Kidwell, GA | 1 |
Greenspon, AJ | 1 |
Greenberg, RM | 1 |
Volosin, KJ | 1 |
Johnson, RG | 1 |
Goldberger, AL | 1 |
Thurer, RL | 1 |
Schwartz, M | 1 |
Sirois, C | 1 |
Weintraub, RM | 1 |
Finance, O | 1 |
Manning, A | 1 |
Chatelain, P | 1 |
Schneider, AJ | 1 |
Murray, WB | 1 |
Mentzer, SC | 1 |
Miranda, F | 1 |
Vaduva, S | 1 |
Haussmann, R | 1 |
Fleischer, F | 1 |
Christmann, G | 1 |
Lange, R | 1 |
Martin, E | 1 |
Yamabe, H | 1 |
Tsuchiya, T | 2 |
Tabuchi, T | 1 |
Yasue, H | 1 |
Miyazaki, T | 1 |
Mitamura, H | 1 |
Miyoshi, S | 1 |
Soejima, K | 1 |
Hamdan, M | 1 |
Hart, K | 1 |
Fitzpatrick, A | 1 |
Kowey, PR | 1 |
Gorgels, AP | 2 |
van den Dool, A | 1 |
Hofs, A | 1 |
Mulleneers, R | 1 |
Smeets, JL | 1 |
Vos, MA | 2 |
Wellens, HJ | 2 |
Josephson, ME | 1 |
Takemura, N | 1 |
Washizu, M | 1 |
Koyama, H | 1 |
Motoyoshi, S | 1 |
Roth, A | 1 |
Malov, N | 1 |
Bloch, Y | 1 |
Schlesinger, Z | 1 |
Laniado, S | 1 |
Kaplinski, E | 1 |
De Micheli, A | 1 |
Medrano, GA | 1 |
Iturralde, P | 1 |
Casanova, JM | 1 |
Murasato, Y | 2 |
Nagamoto, Y | 2 |
Urabe, T | 2 |
Kuraoka, F | 2 |
Nakashima, Y | 2 |
Kuroiwa, A | 2 |
Peters, RW | 1 |
Gilbert, TB | 1 |
Johns-Walton, S | 1 |
Gold, MR | 1 |
Marill, KA | 1 |
Greenberg, GM | 1 |
Kay, D | 1 |
Nelson, BK | 1 |
Zaputović, L | 1 |
Mavrić, Z | 1 |
Zaninović-Jurjević, T | 1 |
Matana, A | 1 |
Bradić, N | 1 |
Hancock, EW | 3 |
Nakamura, W | 1 |
Segawa, K | 1 |
Tanaka, S | 1 |
Yoshimoto, N | 1 |
Derlet, RW | 1 |
Cannom, DS | 1 |
Prystowsky, EN | 1 |
De Groot, SH | 1 |
Leunissen, JD | 1 |
Hermans, M | 1 |
Dohmen, LR | 1 |
Fujiki, A | 1 |
Usui, M | 1 |
Nagasawa, H | 1 |
Mizumaki, K | 1 |
Hayashi, H | 1 |
Inoue, H | 1 |
Sadowski, ZP | 1 |
Skrabucha, B | 1 |
Dyduszynski, A | 1 |
Kuch, J | 1 |
Nartowicz, E | 1 |
Swiatecka, G | 1 |
Kong, DF | 1 |
Olshansky, B | 1 |
DeBehnke, DJ | 1 |
Laundrie, D | 1 |
Van Herreweghe, I | 1 |
Mertens, K | 1 |
Maes, V | 1 |
Ramet, J | 1 |
Watanabe, T | 1 |
Yamaki, M | 1 |
Tachibana, H | 1 |
Yamauchi, S | 1 |
Kubota, I | 1 |
Tomoike, H | 1 |
Groban, L | 1 |
Deal, DD | 1 |
Vernon, JC | 1 |
James, RL | 1 |
Butterworth, J | 1 |
Lemarbre, F | 1 |
Benito Bartolomé, F | 1 |
Funes Moñux, R | 1 |
Lentini, S | 1 |
Rao, ML | 1 |
Schröder, R | 1 |
Lüderitz, B | 1 |
Bauriedel, G | 1 |
Chinushi, Y | 1 |
Toida, T | 1 |
Maeda, Y | 1 |
Funakoshi, S | 1 |
Nakamura, M | 1 |
Fukuzawa, M | 1 |
Kugaya, Y | 1 |
Yamasaki, M | 1 |
Tsukiai, S | 1 |
Murakami, T | 1 |
Takano, M | 1 |
Abe, T | 1 |
Kirigaya, H | 1 |
Nakada, M | 1 |
Zhang, L | 1 |
Li, S | 1 |
Liu, Q | 1 |
Luo, H | 1 |
Xiao, J | 1 |
Xue, Z | 1 |
Tsukada, K | 1 |
Akizuki, S | 1 |
Matsuoka, Y | 1 |
Irimajiri, S | 1 |
Krejcy, K | 1 |
Krumpl, G | 1 |
Todt, H | 1 |
Raberger, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Etiology, Incidence and Survival of Pediatric Out-of-hospital Cardiac Arrests: a Four-year Danish Analysis[NCT04275856] | 300 participants (Anticipated) | Observational [Patient Registry] | 2019-02-01 | Active, not recruiting | |||
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)[NCT01401647] | Phase 3 | 3,024 participants (Actual) | Interventional | 2012-05-31 | Completed | ||
PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN PATIENTS WITH STABLE VENTRICULAR TACHYCARDIA IN THE EMERGENCY ROOM[NCT03299517] | Phase 4 | 80 participants (Anticipated) | Interventional | 2017-08-02 | Recruiting | ||
An Investigation Into the Effects of Intravenous Lipid Emulsion (ILE) on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.[NCT02924454] | Phase 4 | 10 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies[NCT03182777] | 31 participants (Actual) | Interventional | 2015-05-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Neurologic status at discharge will be assessed using the modified Rankin Score (MRS). A higher value indicates a worse outcome. 0-No symptoms at all; 1-No significant disability despite symptoms; able to carry out all usual duties and activities, 2-Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance, 3-Moderate disability; requiring some help, but able to walk without assistance; 4-Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance, 5-Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6-Dead (NCT01401647)
Timeframe: Patients will be followed from the time of the cardiac arrest until death, hospital discharge, or December 31, 2015, whichever occurs first.
Intervention | Participants (Count of Participants) |
---|---|
Amiodarone | 182 |
Lidocaine | 172 |
Normal Saline | 175 |
Patients may die in the field (outside of the hospital at the time of the cardiac arrest), at the emergency room, in the hospital, or they are discharged alive from the hospital. (NCT01401647)
Timeframe: Patients will be followed from the time of the cardiac arrest until death, hospital discharge, or December 31, 2015, whichever occurs first.
Intervention | participants (Number) |
---|---|
Amiodarone | 237 |
Lidocaine | 233 |
Normal Saline | 222 |
10 reviews available for lidocaine and Tachycardia, Ventricular
Article | Year |
---|---|
Antiarrhythmic drug therapy during cardiopulmonary resuscitation: should we use it?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiopulm | 2018 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, H | 2017 |
Amiodarone supplants lidocaine in ACLS and CPR protocols.
Topics: Action Potentials; Advanced Cardiac Life Support; Amiodarone; Anti-Arrhythmia Agents; Bretylium Comp | 2011 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 2003 |
Ventricular tachyarrhythmias (out of hospital cardiac arrests).
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Electric Countershock; Humans; Lidocaine; T | 2006 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiograp | 1993 |
An overview of antiarrhythmic drug management of electrical storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Humans; Infusions, Intravenous; Lidoca | 1996 |
Management of ventricular arrhythmias: detection, drugs, and devices.
Topics: Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiovascula | 1999 |
Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction.
Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; | 1999 |
[A case of aconitine poisoning accompanied by bidirectional ventricular tachycardia treated with lidocaine].
Topics: Aconitine; Aged; Humans; Lidocaine; Male; Tachycardia, Ventricular | 1992 |
12 trials available for lidocaine and Tachycardia, Ventricular
Article | Year |
---|---|
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Central Nervous Syst | 2016 |
Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiograp | 2009 |
Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Female; | 2010 |
Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; El | 2002 |
Effects of antiarrhythmic agents on left ventricular function during exercise in patients with chronic left ventricular dysfunction.
Topics: Aged; Anti-Asthmatic Agents; Chronic Disease; Disopyramide; Exercise; Exercise Test; Female; Heart V | 2004 |
Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; S | 1994 |
Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Electric Stimulation; Female; Humans; Injections, | 1994 |
Lidocaine prophylaxis in coronary revascularization patients: a randomized, prospective trial.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Output, Low; Coronary Artery Bypa | 1993 |
"Helper:" A critical events prompter for unexpected emergencies.
Topics: Algorithms; Anesthesia, General; Anesthesiology; Anti-Arrhythmia Agents; Bradycardia; Clinical Proto | 1995 |
Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Infusions, Intravenous; Lidocaine; Male | 1996 |
Relationship between QT dispersion and the incidence of early ventricular arrhythmias in patients with acute myocardial infarction.
Topics: Aged; Chi-Square Distribution; Creatine Kinase; Electric Countershock; Electrocardiography; Electrol | 1997 |
Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction.
Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; | 1999 |
125 other studies available for lidocaine and Tachycardia, Ventricular
Article | Year |
---|---|
Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperch
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Crystallog | 1996 |
Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxicity; Drug Overdose; Fema | 2022 |
The imperfect storm: An uncommon presentation of Chagas disease.
Topics: Arrhythmias, Cardiac; Chagas Disease; Defibrillators, Implantable; Humans; Lidocaine; Tachycardia, V | 2022 |
Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry.
Topics: Adult; Amiodarone; Cardiopulmonary Resuscitation; Electric Countershock; Emergency Medical Services; | 2022 |
Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Lidocaine; Tachycardia, Ventricular; Ventricular Fibrillat | 2023 |
Ventricular Tachycardia Storm After Standard Radiofrequency Pulmonary Vein Isolation.
Topics: Aged; Anti-Arrhythmia Agents; Cicatrix; Electric Countershock; Heart Ventricles; Humans; Lidocaine; | 2019 |
Concurrent increases in post-pacing action potential duration and contractility predict occurrence of ventricular arrhythmia.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Heart; Heart Rate; Lidocaine; Male; Myocardial C | 2020 |
Local Anesthetic Toxicity Following Infusion of Lidocaine for Postoperative Ventricular Tachycardia in the Cardiovascular Intensive Care Unit.
Topics: Anesthetics, Local; Arrhythmias, Cardiac; Humans; Intensive Care Units; Lidocaine; Tachycardia, Vent | 2021 |
Ventricular Tachycardia and Cardiovascular Collapse following Flexible Bronchoscopy: Lidocaine Cardiotoxicity.
Topics: Aged; Anesthetics, Local; Bronchoscopy; Cardiopulmonary Resuscitation; Cardiotoxicity; Electric Coun | 2018 |
March 26th Question.
Topics: Ablation Techniques; Action Potentials; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, A | 2018 |
Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
Topics: Administration, Intravenous; Adult; Aged; Brugada Syndrome; Death, Sudden, Cardiac; Electrocardiogra | 2018 |
Lidocaine toxicity in the setting of HeartMate II left ventricular assist device.
Topics: Aged; Anti-Arrhythmia Agents; Heart Failure; Heart-Assist Devices; Humans; Lidocaine; Male; Tachycar | 2018 |
2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Em
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emerg | 2018 |
2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Child | 2018 |
Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Heart Ar | 2020 |
Changing U.S. guidelines on lidocaine for stable monomorphic ventricular tachycardia: Have emergency medical services kept pace?
Topics: Anti-Arrhythmia Agents; Clinical Protocols; Cross-Sectional Studies; Emergency Medical Services; Gui | 2019 |
Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disease Mode | 2013 |
Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Femal | 2014 |
Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiological Pheno | 2014 |
Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Cohort Studies; Heart Arres | 2014 |
Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Huma | 2014 |
Verapamil-sensitive idiopathic left ventricular tachycardia in a 6-month-old: unique considerations in diagnosis and management in an infant.
Topics: Adenosine; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Female; Heart Ventricle | 2015 |
Ventricular tachycardia and prolonged QT interval presenting as seizure-like activity.
Topics: Adult; Alcoholism; Anti-Arrhythmia Agents; Anticonvulsants; Diuretics; Electrocardiography; Emergenc | 2017 |
A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia.
Topics: Adenine; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiotonic Agents; Electric Cou | 2017 |
Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks.
Topics: Anesthetics, Local; Autonomic Nerve Block; Bupivacaine; Electrocardiography; Heart; Heart Failure; H | 2017 |
Electroanatomic mapping of the left ventricle in a porcine model of chronic myocardial infarction with magnetic resonance-based catheter tracking.
Topics: Animals; Catheter Ablation; Catheterization; Disease Models, Animal; Electrophysiologic Techniques, | 2008 |
In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant.
Topics: Age of Onset; Anti-Arrhythmia Agents; Atrioventricular Block; ERG1 Potassium Channel; Ether-A-Go-Go | 2008 |
Cardiac memory T-wave changes after ventricular tachycardia in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Echocardiography; Electrocardiography; Female; Humans; Lidocaine; Pre | 2008 |
Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Antidotes; Arrhythmias, Cardiac; Charcoal; Coca | 2008 |
Mapping ventricular fibrillation: a simplified experimental model leads to a complicated result.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Disease Models, Animal; Electrophysiolo | 2009 |
Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Chi-Square Distribution; Female; Humans; Lidocaine; Male; Middle Aged; | 2010 |
Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; CHO Cells; Cricetinae; Cricetulus; Drug Evalu | 2010 |
Ventricular fibrillation diagnosed during electrophysiological study for non-sustained tachycardia.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Japan; Lidocaine; Male | 2010 |
Acute amiodarone promotes drift and early termination of spiral wave re-entry.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease | 2010 |
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Confidence Intervals; Dose-Response Relati | 2011 |
Drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction: What does the crystal ball tell you?
Topics: Amiodarone; Anti-Arrhythmia Agents; Critical Care; Critical Illness; Electrocardiography; Female; Hu | 2011 |
First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model.
Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Enzyme Inhibitors; Female; Infusions, Intravenous; In | 2011 |
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calsequestrin; Defi | 2011 |
Idiopathic ventricular tachycardia in a newborn: immediate response to lidocaine.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Infant, Newborn; Lidocaine; Signal Proc | 2011 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Def | 2011 |
A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity.
Topics: Amiodarone; Anesthetics, Local; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; DNA Mutational A | 2012 |
Pilsicainide-induced polymorphic ventricular tachycardia.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Lidocaine; Tachycard | 2012 |
Long QT syndrome, amiodarone use, and the mechanism underlying lidocaine toxicity.
Topics: Anesthetics, Local; Anti-Arrhythmia Agents; Humans; Lidocaine; Long QT Syndrome; Male; Tachycardia, | 2012 |
Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Defibrillators, Implantable; Drug-Eluti | 2012 |
Prenatal diagnosis and treatment of fetal long QT syndrome: a case report.
Topics: Adult; Bradycardia; Bundle-Branch Block; Electrocardiography; Female; Fetal Diseases; Heart Block; H | 2002 |
Hyperkalemia and ventricular tachycardia in ELBW infant.
Topics: Anti-Arrhythmia Agents; Calcium Gluconate; Drug Therapy, Combination; Fatal Outcome; Female; Glucona | 2003 |
[Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Drug Resistance; Emergency Medic | 2003 |
Spatiotemporal dynamics of reentrant ventricular tachycardias in canine myocardial infarction: pharmacological modulation.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electrocardiography; Female; Heart Rate; In Vitro Techniques; | 2003 |
Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Drug Resistance; Electric Countershock; Electr | 2003 |
Recognition of fascicular tachycardia in the emergency department.
Topics: Adenosine; Bundle-Branch Block; Calcium Channel Blockers; Drug Resistance; Electrocardiography; Emer | 2003 |
THE CHEMOTHERAPY OF CARDIAC ARREST.
Topics: Acidosis; Arrhythmias, Cardiac; Bicarbonates; Brugada Syndrome; Cardiac Conduction System Disease; C | 1965 |
Electrical storm: case series and review of management.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Obesity Agents; B | 2003 |
Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors.
Topics: alpha-MSH; Animals; Coronary Disease; Cosyntropin; Female; FMRFamide; gamma-MSH; Hypotension; Inject | 2003 |
Verapamil sensitive idiopathic ventricular tachycardia in an infant.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Resistance; Drug Therapy, Combination; Electrocardiography; | 2003 |
Mechanism of ST elevation and ventricular arrhythmias in an experimental Brugada syndrome model.
Topics: Animals; Disease Models, Animal; Dogs; Electrocardiography; Female; In Vitro Techniques; Lidocaine; | 2004 |
Images in cardiovascular medicine. Fatal bidirectional and polymorphic ventricular tachycardia with terminal depolarization abnormality in a child.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Combined Modality Therap | 2004 |
Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Drug Combinations; Hemodynamics; Lidocaine; Male; Myocar | 2004 |
Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, C | 2004 |
Atropine-triggered idiopathic ventricular tachycardia in an asymptomatic pediatric patient.
Topics: Anesthetics, Intravenous; Anti-Arrhythmia Agents; Atracurium; Atropine; Bronchodilator Agents; Child | 2004 |
A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia.
Topics: Bradycardia; Cell Line; DNA Mutational Analysis; Female; Humans; Infant, Newborn; Lidocaine; Long QT | 2004 |
A case of the toxicity of pilsicainide hydrochloride with comparison of the serial serum pilsicainide levels and electrocardiographic findings.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Creatinine; Drug Overdose; Ele | 2004 |
Sodium stibogluconate and polymorphic ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Electric Countershoc | 2005 |
Effect of lidocaine and amiodarone on transmural heterogeneity of ventricular repolarization in isolated rabbit hearts model of sustained global ischemia.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart V | 2005 |
[Case in which magnesium sulfate effectively treated ventricular tachycardia due to overdose of pilsicainide hydrochloride].
Topics: Adult; Anti-Asthmatic Agents; Drug Overdose; Hemoperfusion; Humans; Infusions, Intravenous; Lidocain | 2006 |
Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hear | 2006 |
Pilsicainide-induced verapamil sensitive idiopathic left ventricular tachycardia.
Topics: Adult; Anti-Arrhythmia Agents; Drug Combinations; Electrocardiography; Humans; Lidocaine; Male; Tach | 2006 |
Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
Topics: Action Potentials; Animals; Cardiovascular Agents; Disease Models, Animal; Dogs; Electrocardiography | 2006 |
Images in cardiovascular medicine. Ventricular tachycardia: the spectrum continues to broaden: report of Naxos disease.
Topics: Bundle-Branch Block; Cardiomyopathies; Electrocardiography; Female; Hair Diseases; Humans; Lidocaine | 2006 |
Spontaneous polymorphic ventricular tachycardia after administration of pilsicainide in a patient resuscitated from ventricular fibrillation.
Topics: Adult; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Electric Countershock; Humans; Lidocai | 2006 |
Pilsicainide-induced ventricular tachycardia originating from right ventricular outflow tract.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Lidocaine; Middle Aged; Tachycardia, Ve | 2007 |
Autonomic and pharmacological responses of idiopathic ventricular tachycardia arising from the left ventricular outflow tract.
Topics: Adenosine Triphosphate; Anti-Arrhythmia Agents; Cardiotonic Agents; Catheter Ablation; Electrophysio | 2007 |
Recurrent life-threatening ventricular dysrhythmias associated with acute hydrofluoric acid ingestion: observations in one case and implications for mechanism of toxicity.
Topics: Aged, 80 and over; Calcium Chloride; Electric Countershock; Electrocardiography; Emergency Service, | 2008 |
Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Catheter Ablation; Electrocardiography; Electrophysiologic | 2008 |
Treatment of tricyclic antidepressant cardiac toxicity.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Child, Preschool; Humans; Hydrogen-Ion Concentratio | 2008 |
Successful resuscitation after ropivacaine and lidocaine-induced ventricular arrhythmia following posterior lumbar plexus block in a child.
Topics: Adolescent; Amides; Anesthetics, Local; Electrocardiography; Emergency Treatment; Fat Emulsions, Int | 2008 |
Facilitation of reentry by lidocaine in canine myocardial infarction.
Topics: Animals; Blood Pressure; Cardiac Complexes, Premature; Dogs; Electric Stimulation; Electrocardiograp | 1994 |
Anaesthetic induction in a child with end-stage cardiomyopathy.
Topics: Anesthesia, Intravenous; Cardiomyopathy, Dilated; Child; Enteral Nutrition; Etomidate; Gastroscopy; | 1995 |
Hypertension and tachycardia during adrenal manipulation.
Topics: Adrenal Glands; Follow-Up Studies; Humans; Hypertension; Intraoperative Complications; Kidney Transp | 1995 |
Low dose lidocaine combined with magnesium sulfate in warning ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiograph | 1993 |
Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction.
Topics: Animals; Dogs; Electrocardiography; Female; Heart Conduction System; Heart Rate; Lidocaine; Male; My | 1994 |
Facilitation of reentry by lidocaine in canine myocardial infarction.
Topics: Acute Disease; Animals; Chronic Disease; Dogs; Electrocardiography; Electrophysiology; Heart Conduct | 1994 |
Ventricular tachycardia and myocardial dysfunction in a horse.
Topics: Animals; Anti-Infective Agents; Echocardiography; Electrocardiography; Horse Diseases; Horses; Lidoc | 1994 |
Differential effects of lignocaine and hypercalcaemia on anisotropic conduction and reentry in the ischaemically damaged canine ventricle.
Topics: Animals; Anisotropy; Dogs; Electrophysiology; Female; Heart Conduction System; Hypercalcemia; Lidoca | 1995 |
Treatment of ventricular tachycardia.
Topics: Humans; Lidocaine; Procainamide; Sotalol; Tachycardia, Ventricular | 1994 |
Pediatric ventricular tachycardia: a review with three illustrative cases.
Topics: Child, Preschool; Combined Modality Therapy; Electrocardiography; Female; Humans; Infant; Infant, Ne | 1994 |
Effects of magnesium sulfate and lidocaine in the treatment of ventricular arrhythmias in experimental amitriptyline poisoning in the rat.
Topics: Amitriptyline; Analysis of Variance; Animals; Blood Pressure; Electrocardiography; Heart Rate; Lidoc | 1994 |
The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds; Bridged Bicyclo Co | 1993 |
Neurotoxicity of lidocaine combined with mexiletine.
Topics: Administration, Oral; Cardiomyopathies; Drug Therapy, Combination; Humans; Injections, Intravenous; | 1993 |
Induction and the possible mechanism of ventricular tachycardia after catheter ablation with direct current shocks in dogs.
Topics: Animals; Bundle of His; Cardiac Pacing, Artificial; Catheter Ablation; Dogs; Electrocardiography, Am | 1993 |
Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Mal | 1993 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
[Anesthesiologic management in cardiomyoplasty].
Topics: Adult; Aged; Anesthesia, General; Anti-Arrhythmia Agents; Cardiomyoplasty; Cardiotonic Agents; Dobut | 1995 |
Characteristics of slow conduction zone demonstrated during entrainment of idiopathic ventricular tachycardia of left ventricular origin.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Female; Heart Con | 1996 |
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Humans; | 1996 |
Munchausen's syndrome by telemetry.
Topics: Adult; Diagnosis, Differential; Electric Countershock; Humans; Lidocaine; Male; Munchausen Syndrome; | 1996 |
Lidocaine and sustained monomorphic ventricular tachycardia: fact or fiction.
Topics: Anti-Arrhythmia Agents; Humans; Infusions, Intravenous; Lidocaine; Procainamide; Tachycardia, Ventri | 1996 |
Multifocal ventricular tachycardia after resuscitation by direct current counter shock in a dog.
Topics: Animals; Blood Volume; Dog Diseases; Dogs; Electric Countershock; Electrocardiography; Heart Arrest; | 1996 |
Usefulness of self-administration of intramuscular lidocaine in the prehospital setting for ventricular tachyarrhythmias unassociated with acute myocardial infarction (the "Shahal" experience in Israel).
Topics: Adult; Aged; Aged, 80 and over; Ambulances; Angina Pectoris; Anti-Arrhythmia Agents; Critical Care; | 1997 |
Effects of verapamil in ventricular tachycardias. An experimental and clinical study.
Topics: Aconitine; Adult; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Dogs; Electrocardiogr | 1997 |
Effects of lidocaine and diltiazem on recovery of electrophysiologic activity during partial reperfusion following severe myocardial ischemia in canine hearts.
Topics: Animals; Anti-Arrhythmia Agents; Blood Flow Velocity; Coronary Vessels; Diltiazem; Disease Models, A | 1997 |
[Etiologies of electric storm].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Electric Countershock; Female; Hemodyn | 1997 |
Lidocaine-related increase in defibrillation threshold.
Topics: Anesthesia, Intravenous; Anesthetics, Local; Anti-Arrhythmia Agents; Defibrillators, Implantable; El | 1997 |
Analysis of the treatment of spontaneous sustained stable ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Failure; Humans; Injections, Intravenous; | 1997 |
Effects of lidocaine and diltiazem on ventricular tachyarrhythmia and dispersion of conduction during severe myocardial ischemia in canine hearts.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Dogs; Heart Conduction System; Lidocaine; Myocardial I | 1997 |
Sudden tachycardia in an octagenarian.
Topics: Adenosine; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Coronary Disease; Diagnosis, Differentia | 1998 |
Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia.
Topics: Anti-Arrhythmia Agents; Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Fle | 1998 |
More on lidocaine use in cocaine toxicity.
Topics: Anti-Arrhythmia Agents; Cocaine-Related Disorders; Drug Monitoring; Humans; Lidocaine; Tachycardia, | 1998 |
The dynamic behavior of the diastolic slope of monophasic action potential can be related to the occurrence and maintenance of delayed afterdepolarization dependent arrhythmias.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Diastole; Dogs; Elec | 1999 |
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Hea | 1999 |
Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiovascular Surgical Procedures; Clinica | 1998 |
Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes.
Topics: Aged; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Electric Countershock; Electrocardiogra | 1999 |
A 55-year-old man with acute myocardial infarction develops tachycardia following balloon angioplasty.
Topics: Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Electrocardiography; Humans; Lidocaine; Male | 1999 |
Orphenadrine poisoning in a child: clinical and analytical data.
Topics: Akathisia, Drug-Induced; Anti-Arrhythmia Agents; Anticonvulsants; Antiparkinson Agents; Ataxia; Chil | 1999 |
Irregular rhythm after cardiac surgery.
Topics: Adult; Anti-Arrhythmia Agents; Aortic Aneurysm, Thoracic; Electrocardiography; Heart Block; Humans; | 1999 |
Anisotropic effects of sodium channel blockers on the wavelength for ventricular excitation in dogs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electr | 2000 |
Ventricular arrhythmias with or without programmed electrical stimulation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine.
Topics: Amides; Anesthetics, Local; Animals; Bupivacaine; Cardiac Pacing, Artificial; Dogs; Drug Overdose; L | 2000 |
Onset dynamics of reentrant tachycardia and rate-dependent conduction changes in canine ventricular muscle: effects of Na+ and Ca2+ channel blockade.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Pacing, Artificial; Data Interpre | 2000 |
Effects of verapamil and lidocaine on two components of the re-entry circuit of verapamil-senstitive idiopathic left ventricular tachycardia.
Topics: Adolescent; Adult; Bundle-Branch Block; Cardiac Pacing, Artificial; Electrocardiography; Female; Hea | 2001 |
[Efficacy of lidocaine in neonatal ischemic ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Humans; Infant, Newborn; Lidocaine; Male; Myocardial Ischemia; Postoperative | 2001 |
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Topics: Aged; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Coronary Angiography; Diagno | 2001 |
Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina.
Topics: Acetylcholine; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2002 |
Possible mechanism for pharmacokinetic interaction between lidocaine and mexiletine.
Topics: Aged; Aged, 80 and over; Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Drug Interactions | 2002 |
J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome?
Topics: Adult; Bundle-Branch Block; Diagnosis, Differential; Electrocardiography; Humans; Lidocaine; Male; S | 2002 |
[Relation between the occurrence of malignant arrhythmia during acute myocardial ischemia and the weight of ischemic myocardium in goats].
Topics: Animals; Goats; Lidocaine; Male; Myocardial Ischemia; Myocardium; Tachycardia, Ventricular; Ventricu | 1992 |
Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
Topics: Animals; Arrhythmias, Cardiac; Consciousness; Dogs; Dose-Response Relationship, Drug; Electric Stimu | 1992 |